Deleting dihydroceramide desaturase 1 (DES1) in the liver resolved hepatic steatosis and improved insulin sensitivity in diet-induced obese mice by increasing the dihydroceramide (DCER) levels that decreased ceramide species with a critical double bond [106]. Here, INS is linked to fatty liver disease.